Patent applications published 14 July 2010
Selected patent applications from the weekly European Patents Bulletin
- Combretum laurifolium mart extract and methods of extracting and using extract
 Selvamedica 2205069*
 
- N-hydroxy-naphthalene dicarboxamide and N-hydroxy-biphenyl-dicarboxamide compounds as histone deacetylase inhibitors
 Merck Sharp &_Dohme 2205070*
 
- Methods for treating pressure induced optical neuropathy, preventing neuronal degeneration and promoting neuronal cell survival via administration of Lingo-1 antagonists and TRKB_agonists
 Biogen Idec 2205071*
 
- Methods for treating a variety of diseases and conditions, and compounds useful therefore
 The Salk Institute for Biological Studies 2205072*
 
- Azacystidine analogues and uses thereof
 Mount Sinai School of Medicine; Clavis Pharma 2205073*
 
- Meonomycin analogues, methods of synthesis and uses thereof
 President and Fellows of Harvard College 2205074*
 
- Therapies of treating cancer using combinations of COX-2 inhibitors and aromatase inhibitors or combinations of COX-2 inhibitors and oestrogen receptor antagonists
 Tragara Pharmaceuticals 2205075*
 
- Combination therapy for the treatment of cancer using COX-2 inhibitors and dual inhibitors of EGFR_[ERBB1] and HER-2 [ERBB2] 
 Tragara Pharmaceuticals 2205076*
 
- Therapies for treating cancer using combinations of COX-2 inhibitors and anti-HER2 (ERBB2) antibodies or COX-2 inhibitors and HER2 (ERBB2) receptor tyrosine kinase inhibitors
 Tragara Pharmaceuticals 2205077*
 
- Production of moatin stereoisomers
 Cargill Inc 2205078*
 
- N-substituted oxindoline derivatives as calcium channel blockers
 Merck Sharp &_Dohme 2205079*
 
- Substituted aryl sulphone derivatives as calcium channel blockers
 Merck Sharp &_Dohme; Neuromed Pharmaceuticals 2205083*
 
- 2-aryl or heteroaryl indole derivatives
 Merck Sharp &_Dohme 2205085*
 
- Naphthalene-based inhibitors of anti-apoptotic proteins
 Burnham Institute for Medical Research 2205088*
 
- Extrudable and extruded compsns for delivery of bioactive agents, method of making the same and method of using same
 Philip Morris Products 2205227*
 
- Compounds and methods for pharmaceutical use
 Mintails 2205229*
 
- Pharmaceutical compsns of 5-hydroxy-tryptophan and serotonin-enhancing compound
 NeuroSearch 2205231*
 
- Galenical formulations of aliskiren
 Novartis 2205232*
 
- Galenical formulations of aliskiren and valsartan
 Novartis 2205233*
 
- Methods and compsns for treating retinol-related diseases
 Sirion Therapeutics 2205234*
 
- Formulation to improve gastrointestinal function
 University of Florida Research Foundation 2205235*
 
- Novel agents for treatment of ailments and dysfunctions
 Regain Biotechnology 2205236*
 
- Methods for protecting the skin from radiation insults
 Johns Hopkins University 2205237*
 
- Combination therapy related to serotonin dual action compounds
 H Lundbeck 2205238*
 
- Pyrrolo [1,2-C] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies
 Takeda Pharmaceutical 2205239*
 
- Endocannabinoids for enhancing growth and development in infants
 Ariel-University Research and Develop-ment Company; Ben Gurion University of the Negev Research and Development Authority; Hadasit Medical Research Sciences and Development 2205240*
 
- Polo-like kinase inhibitors
 Takeda Pharmaceutical Co 2205241*
 
- Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use
 Genentech; F_Hoffmann-La Roche 2205242*
 
- Mast cell stabilisers in treatment of obesity
 The Brigham and Women’s Hospital 2205243*
 
- Methods of administering N-9%-tert-nutyl-isoxazol-3-yl)-N’-[4-[7-(2-morpholin-4-yl-ethoxy)imidazo]2,1-B[1,3]-benzothiol-2-yl]-phenyl)-urea to treat proliferative disease
 Ambit Biosciences 2205244*
 
- Therapeutic use of diaminophenothiazines
 Wista Laboratories 2205245*
 
- Compsns comprising quinolone and methods for treating or controlling infections
 Bausch &_Lomb 2205246*
 
- Inhibitor of norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC7 ion channels
 Sanofi-Aventis 2205247*
 
- Combination of nitroderivatized steroid and bronchodilator for treating respiratory disease
 Nicox 2205248